Please activate JavaScript!
Please install Adobe Flash Player, click here for download

Dental Tribune Chinese Edition

人物专访 9 www.dentistx.com academics together with associations and societies, eg, CSA(Chinese Stomatological Association) but also universities. DTI:什么使得盖氏成为全球再 生领域的先锋? What made Geistlich Pharma a global player in the field of regeneration? Paul Note:创新一直是盖氏的核 心价值之一,我们一直在对诸如软组 织再生等新的适应症进行研究及探索。 现在Geistlich Bio-Oss®和Geistlich Bio- Gide®这两种产品已被大家所熟知,我 可以告诉大家,很多盖氏的新产品在 欧洲及美国已经获得了很好的市场反 馈,其中一些也即将通过中国政府部门 的审批。当然,盖氏是一家拥有悠久历 史的家族企业而非上市公司,因此我们 并不局限于眼前的利益,而是从长远的 角度推动产品创新,保持公司的可持续 发展。Geistlich Pharma is always looking for further indications in new areas such as soft tissue regeneration. Those who already know Geistlich Bio-Oss® and Geistlich Bio-Gide®, know what they can expect from our products and what they can offer to their patients. Our highest priority is that this remains so. And due to the fact that we are a family owned company, which is independent from the stock market we do not have to follow every passing trend but we can develop our innovative products in a responsible way with a long term view. DTI:创新就意味着不断地有新 产品推出吗? What does this mean for new products? Paul Note:盖氏的宗旨是以科研 为基础,不能急功近利。这意味着通 过与遍及全球的专家学者的合作,我 们对产品进行了大量的实验并积累了 相当数量的文献,当然这其中来自临 床的验证是不可或缺的环节。只有对新 产品的质量及有效性有充分的信心,我 们才会将其推向市场。Geistlich's policy of a scientific based approach is not about commercializing innovations as quickly as possible. This means that we test and docu- ment our products in close co-operation with scientists from many universities from all over the world and – of course - with our partners from clinical practice. Only when we are completely satisfied with the quality and the efficiency of our new products we launch them onto the market. DTI:盖氏建立骨再生基金会的 初衷是什么? Why did Geistlich Pharma establish the Osteology foundation? Paul Note:自2003年骨再生基 金会Osteology Foundation由Dr. Peter Geistlich创建以来,一直致力于向临床 治疗提供经科学测试证实的最新产品 和技术,病人以此可以得到更好的治 疗。我们可以很自豪地说骨再生基金会 Osteology Foundation对口腔组织再生领 域的创新发展发挥了极为重要的推动作 用。Dr. Peter Geistlich set up the Osteol- ogy foundation in 2003 with the objective to provide targeted support to bring faster new techniques and products which had been sufficiently tested and documented into hospitals and practices. At the same time improved therapeutic approaches for patients should be achieved. Today we are proud being able to say that the Foundation is one of the most important drivers of in- novation in oral tissue regeneration. DTI:骨再生基金会Osteology Foundation对中国的口腔事业有什么帮 助? How can China’s dentistry benefit from this relationship? Paul Note:骨再生基金会Osteology Foundation是一个严谨独立的学术机 构,这一点很重要。该基金会不断探 索临床科学发展方向,并把握时机对 实际项目予以支持,以确保得到临床 治疗所需要的循证医学解决方案。另 外,通过对这些科研项目的支持,骨 再生基金会Osteology Foundation还致力 于获取更可靠的临床数据,为患者的康 复提供保障。 It is important to know that the Foundation has established itself to a credible, independent institution. By funding projects via grants the Founda- tion has identified gaps, opportunities and potentials and determined what research requirements actually exist. This enables us to create evidence-based solutions that practitioners need.As a result of its activi- ties to improve the quality of research the Foundation contributes to create solid data, for the benefit of the patients future health.

Pages Overview